Loading clinical trials...
Loading clinical trials...
S0521, A Randomized Trial of Maintenance Versus Observation for Patients With Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL), Phase III
Conditions
Interventions
mercaptopurine
methotrexate
+1 more
Locations
210
United States
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Sutter Cancer Center at Roseville Medical Center
Roseville, California, United States
Sutter Cancer Center
Sacramento, California, United States
Stanford Cancer Center
Stanford, California, United States
Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
CCOP - Christiana Care Health Services
Newark, Delaware, United States
Start Date
June 1, 2007
Primary Completion Date
December 1, 2013
Completion Date
May 4, 2016
Last Updated
January 10, 2023
NCT06735690
NCT05564390
NCT00131014
NCT03050268
NCT06074666
NCT07320235
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions